What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Instead, it is quickly absorbed by the body and is no longer detectable within minutes of ingestion
Consult the product monograph or a medical professional for complete prescribing information.
This is especially the case after the loading period is finished, to help determine the right frequency thereafter
Summer is one of the best times of the year, but your skin may not Summer is filled with vacations, weddings, reunions, and countless photo opportunities
doi: 10.14336/AD.2021.0302 [PubMed] 34300194 Alolayan YS, McKinley K, Bhatia R, Alkhachroum A